Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Section 32 Fund 1, LP Insider Profile
4 Followers
Section 32 Fund 1, LP, Ten Percent Owner at X4 Pharmaceuticals, holds 1.03M shares in Dave (Ticker: DAVE), holds 451.36K shares in X4 Pharmaceuticals (Ticker: XFOR). Most recently, Section 32 Fund 1, LP Sold ― shares of Dave on Oct 11, 2024 for an estimated value of 40.60M.
Section 32 Fund 1, LP X4 Pharmaceuticals (XFOR)Ten Percent Owner
X4 Pharmaceuticals (XFOR)
Ten Percent Owner
Ranked #16,821 out of 99,060 Corporate Insiders
Profitable Transactions
8 out of 9 Profitable Transactions
Average Return
+9.30%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Section 32 Fund 1, LP holds in companies
Most Profitable Insider Trade
The most profitable trade made by Section 32 Fund 1, LP
Section 32 Fund 1, LP's Trading History
X4 Pharmaceuticals
Nov 20, 2017
Ten Percent Owner
Uninformative Buy
―
$236.06K
Dave
Oct 11, 2024
Ten Percent Owner
Informative Sell
40.60M
$42.40M
List of latest transactions for each holding click on a transaction to see Section 32 Fund 1, LP's performance on stock
You May Also Like
Section 32 Fund 1, LP insider profile FAQ
What is the percentage of profitable transactions made by Section 32 Fund 1, LP?
The percentage of profitable transactions made by Section 32 Fund 1, LP is 89%.
What is the average return per transaction made by Section 32 Fund 1, LP?
The average return per transaction made by Section 32 Fund 1, LP is 9.30%.
What stocks does Section 32 Fund 1, LP hold?
Section 32 Fund 1, LP holds: XFOR, DAVE stocks.
What was Section 32 Fund 1, LP’s latest transaction?
Section 32 Fund 1, LP latest transaction was an Informative Sell of $40.60M.
What was Section 32 Fund 1, LP's most profitable transaction?
Section 32 Fund 1, LP’s most profitable transaction was an Informative Sell of DAVE stock on August 10, 2022. The return on the trade was 68.50%.
What is Section 32 Fund 1, LP's role in X4 Pharmaceuticals?
Section 32 Fund 1, LP's role in X4 Pharmaceuticals is Ten Percent Owner.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.